Ani pharmaceuticals to participate at leerink partners therapeutics forum: i&i and metabolism on july 8th

Princeton, n.j., july 02, 2025 (globe newswire) -- ani pharmaceuticals, inc. (“ani” or the “company”) (nasdaq: anip) today announced that nikhil lalwani, president and chief executive officer, will host 1x1 meetings at the leerink partners therapeutics forum: i&i and metabolism on tuesday, july 8, 2025, in boston, ma.
ANIP Ratings Summary
ANIP Quant Ranking